Coffee decreases the risk of endometrial cancer: A dose–response meta-analysis of prospective cohort studies

Nutrients

Volumn 9, Issue 11, 2017, Pages

  Lafranconi, Alessandra ^a,b   Micek, Agnieszka ^c   Galvano, Fabio ^d   Rossetti, Sabrina ^e   Del Pup, Lino ^f   Berretta, Massimiliano ^f   Facchini, Gaetano ^e  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d UNIVERSITY OF CATANIA   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Caffeine; Coffee; Endometrial cancer; Meta analysis; Postmenopausal; Prospective cohort

Indexed keywords

AGE; BODY MASS; CANCER RISK; COFFEE; DOSE RESPONSE; EDUCATION; ENDOMETRIUM CANCER; HUMAN; META ANALYSIS; POSTMENOPAUSE; REVIEW; SMOKING; ENDOMETRIUM TUMOR; FEMALE; RISK FACTOR;

COFFEE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; POSTMENOPAUSE; RISK FACTORS;

EID: 85034100944     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9111223     Document Type: Review

References (68)

1. Word Health Oranganization. Available online: http://globocan.iarc.fr/Default.aspx (accessed on 4 November 2017).
2. Forouzanfar, M.H.; Alexander, L.; Anderson, H.R.; Bachman, V.F.; Biryukov, S.; Brauer, M.; Burneet, R.; Casey, D.; Coates, M.M.; Cohen, A.; et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2013: A systematic analysis for the global burden of disease study 2013. Lancet 2016, 388, 2287–2323. [CrossRef]
3. Grosso, G.; Bella, F.; Godos, J.; Sciacca, S.; Del Rio, D.; Ray, S.; Galvano, F.; Giovannucci, E. Possible role of diet in cancer: Systematic review and multiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk. Nut. Rev. 2017, 75, 405–419. [CrossRef] [PubMed]
4. Lim, S.S.; Vos, T.; Flaxman, A.D.; Danaei, G.; Shibuya, K.; Adair-Rohani, H.; AlMazroa, M.A.; Amann, M.; Anderson, H.R.; Andrews, K.G.; et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: A systematic analysis for the global burden of disease study 2010. Lancet 2012, 380, 2224–2260. [CrossRef]
5. Grosso, G.; Godos, J.; Galvano, F.; Giovannucci, E.L. Coffee, caffeine, and health outcomes: An umbrella review. Annu. Rev. Nutr. 2017, 37, 131–156. [CrossRef] [PubMed]
6. Grosso, G.; Micek, A.; Godos, J.; Sciacca, S.; Pajak, A.; Martinez-Gonzalez, M.A.; Giovannucci, E.L.; Galvano, F. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: A dose-response meta-analysis. Eur. J. Epidemiol. 2016, 31, 1191–1205. [CrossRef] [PubMed]
7. Marventano, S.; Salomone, F.; Godos, J.; Pluchinotta, F.; Del Rio, D.; Mistretta, A.; Grosso, G. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies. Clin. Nutr. 2016, 35, 1269–1281. [CrossRef] [PubMed]
8. Godos, J.; Micek, A.; Marranzano, M.; Salomone, F.; Rio, D.D.; Ray, S. Coffee consumption and risk of biliary tract cancers and liver cancer: A dose-response meta-analysis of prospective cohort studies. Nutrition 2017, 9, 950. [CrossRef] [PubMed]
9. Liu, H.; Hu, G.H.; Wang, X.C.; Huang, T.B.; Xu, L.; Lai, P.; Guo, Z.F.; Xu, Y.F. Coffee consumption and prostate cancer risk: A meta-analysis of cohort studies. Nutr. Cancer 2015, 67, 392–400. [CrossRef] [PubMed]
10. Ran, H.Q.; Wang, J.Z.; Sun, C.Q. Coffee consumption and pancreatic cancer risk: An update meta-analysis of cohort studies. Pak. J. Med. Sci. 2016, 32, 253–259. [CrossRef] [PubMed]
11. Gan, Y.; Wu, J.; Zhang, S.; Li, L.; Cao, S.; Mkandawire, N.; Ji, K.; Herath, C.; Gao, C.; Xu, H.; et al. Association of coffee consumption with risk of colorectal cancer: A meta-analysis of prospective cohort studies. Oncotarget 2016, 8, 18699. [CrossRef] [PubMed]
12. Caprioli, G.; Cortese, M.; Sagratini, G.; Vittori, S. The influence of different types of preparation (espresso and brew) on coffee aroma and main bioactive constituents. Int. J. Food Sci. Nutr. 2015, 66, 505–513. [CrossRef] [PubMed]
13. Godos, J.; Pluchinotta, F.R.; Marventano, S.; Buscemi, S.; Li Volti, G.; Galvano, F.; Grosso, G. Coffee components and cardiovascular risk: Beneficial and detrimental effects. Int. J. Food Sci. Nutr. 2014, 65, 925–936. [CrossRef] [PubMed]
14. Je, Y.; Giovannucci, E. Coffee consumption and risk of endometrial cancer: Findings from a large up-to-date meta-analysis. Int. J. Cancer 2012, 131, 1700–1710. [CrossRef] [PubMed]
15. Zhou, Q.; Luo, M.L.; Li, H.; Li, M.; Zhou, J.G. Coffee consumption and risk of endometrial cancer: A dose-response meta-analysis of prospective cohort studies. Sci. Rep. 2015, 5, 13410. [CrossRef] [PubMed]
16. Yang, T.O.; Crowe, F.; Cairns, B.J.; Reeves, G.K.; Beral, V. Tea and coffee and risk of endometrial cancer: Cohort study and meta-analysis. Am. J. Clin. Nutr. 2015, 101, 570–578. [CrossRef] [PubMed]
17. Federation, E.C. Coffee Consumption in Europe. Available online: https://www.ecf-coffee.org/index.php (accessed on 4 November 2017).
18. Grigg, D. The worlds of tea and coffee: Patterns of consumption. GeoJournal 2002, 57, 283–294. [CrossRef]
19. Wang, A.; Wang, S.; Zhu, C.; Huang, H.; Wu, L.; Wan, X.; Yang, X.; Zhang, H.; Miao, R.; He, L.; et al. Coffee and cancer risk: A meta-analysis of prospective observational studies. Sci. Rep. 2016, 6, 33711. [CrossRef] [PubMed]
20. Stroup, D.F.; Berlin, J.A.; Morton, S.C.; Olkin, I.; Williamson, G.D.; Rennie, D.; Moher, D.; Becker, B.J.; Sipe, T.A.; Thacker, S.B. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in epidemiology (moose) group. JAMA 2000, 283, 2008–2012. [CrossRef] [PubMed]
21. Wells, G.A.; Shea, B.; O’Connell, D.; Peterson, J.; Welch, V.; Losos, M.; Tugwell, P. The Newcastle-Ottawa Scale (nos) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses; Ottawa Health Research Institute: Ottawa, ON, Canada, 1999.
22. Greenland, S. Quantitative methods in the review of epidemiologic literature. Epidemiol. Rev. 1987, 9, 1–30. [CrossRef] [PubMed]
23. Greenland, S.; Longnecker, M.P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am. J. Epidemiol. 1992, 135, 1301–1309. [CrossRef] [PubMed]
24. Orsini, N.B.R.; Greenland, S. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2006, 6, 40–57.
25. Orsini, N.; Li, R.; Wolk, A.; Khudyakov, P.; Spiegelman, D. Meta-analysis for linear and nonlinear dose-response relations: Examples, an evaluation of approximations, and software. Am. J. Epidemiol. 2012, 175, 66–73. [CrossRef] [PubMed]
26. Friberg, E.; Orsini, N.; Mantzoros, C.S.; Wolk, A. Coffee drinking and risk of endometrial cancer—A population-based cohort study. Int. J. Cancer 2009, 125, 2413–2417. [CrossRef] [PubMed]
27. Gavrilyuk, O.; Braaten, T.; Skeie, G.; Weiderpass, E.; Dumeaux, V.; Lund, E. High coffee consumption and different brewing methods in relation to postmenopausal endometrial cancer risk in the Norwegian women and cancer study: A population-based prospective study. BMC Women's Health 2014, 14, 48. [CrossRef] [PubMed]
28. Giri, A.; Sturgeon, S.R.; Luisi, N.; Bertone-Johnson, E.; Balasubramanian, R.; Reeves, K.W. Caffeinated coffee, decaffeinated coffee and endometrial cancer risk: A prospective cohort study among us postmenopausal women. Nutrition 2011, 3, 937–950. [CrossRef] [PubMed]
29. Gunter, M.J.; Schaub, J.A.; Xue, X.; Freedman, N.D.; Gaudet, M.M.; Rohan, T.E.; Hollenbeck, A.R.; Sinha, R. A prospective investigation of coffee drinking and endometrial cancer incidence. Int. J. Cancer 2012, 131, E530–E536. [CrossRef] [PubMed]
30. Hashibe, M.; Galeone, C.; Buys, S.S.; Gren, L.; Boffetta, P.; Zhang, Z.F.; La Vecchia, C. Coffee, tea, caffeine intake, and the risk of cancer in the plco cohort. Br. J. Cancer 2015, 113, 809–816. [CrossRef] [PubMed]
31. Je, Y.; Hankinson, S.E.; Tworoger, S.S.; De Vivo, I.; Giovannucci, E. A prospective cohort study of coffee consumption and risk of endometrial cancer over a 26-year follow-up. Cancer Epidemiol. Biomark. Prev. 2011, 20, 2487–2495. [CrossRef] [PubMed]
32. Merritt, M.A.; Tzoulaki, I.; Tworoger, S.S.; De Vivo, I.; Hankinson, S.E.; Fernandes, J.; Tsilidis, K.K.; Weiderpass, E.; Tjonneland, A.; Petersen, K.E.; et al. Investigation of dietary factors and endometrial cancer risk using a nutrient-wide association study approach in the epic and nurses’ health study (NHS) and NHSII. Cancer Epidemiol. Biomark. Prev. 2015, 24, 466–471. [CrossRef] [PubMed]
33. Nilsson, L.M.; Johansson, I.; Lenner, P.; Lindahl, B.; Van Guelpen, B. Consumption of filtered and boiled coffee and the risk of incident cancer: A prospective cohort study. Cancer Causes Control 2010, 21, 1533–1544. [CrossRef] [PubMed]
34. Shimazu, T.; Inoue, M.; Sasazuki, S.; Iwasaki, M.; Kurahashi, N.; Yamaji, T.; Tsugane, S.; JPHC Study Group Members of the Japan Public Health Center-based Prospective Study. Coffee consumption and risk of endometrial cancer: A prospective study in Japan. Int. J. Cancer 2008, 123, 2406–2410. [CrossRef] [PubMed]
35. Uccella, S.; Mariani, A.; Wang, A.H.; Vierkant, R.A.; Cliby, W.A.; Robien, K.; Anderson, K.E.; Cerhan, J.R. Intake of coffee, caffeine and other methylxanthines and risk of Type I vs. Type II endometrial cancer. Br. J. Cancer 2013, 109, 1908–1913. [CrossRef] [PubMed]
36. Weiderpass, E.; Sandin, S.; Lof, M.; Oh, J.K.; Inoue, M.; Shimazu, T.; Tsugane, S.; Adami, H.O. Endometrial cancer in relation to coffee, tea, and caffeine consumption: A prospective cohort study among middle-aged women in Sweden. Nutr. Cancer 2014, 66, 1132–1143. [CrossRef] [PubMed]
37. Bohn, S.K.; Blomhoff, R.; Paur, I. Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol. Nutr. Res. 2014, 58, 915. [CrossRef] [PubMed]
38. Boettler, U.; Sommerfeld, K.; Volz, N.; Pahlke, G.; Teller, N.; Somoza, V.; Lang, R.; Hofmann, T.; Marko, D. Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression. J. Nutr. Biochem. 2011, 22, 426–440. [CrossRef] [PubMed]
39. Gaascht, F.; Dicato, M.; Diederich, M. Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer. Genes Nutr. 2015, 10, 51. [CrossRef] [PubMed]
40. Niseteo, T.; Komes, D.; Belščak-Cvitanović, A.; Horžić, D.; Budeč, M. Bioactive composition and antioxidant potential of different commonly consumed coffee brews affected by their preparation technique and milk addition. Food Chem. 2012, 134, 1870–1877. [CrossRef] [PubMed]
41. Liang, N.; Kitts, D.D. Antioxidant property of coffee components: Assessment of methods that define mechanisms of action. Molecules 2014, 19, 19180. [CrossRef] [PubMed]
42. Grosso, G.; Godos, J.; Lamuela-Raventos, R.; Ray, S.; Micek, A.; Pajak, A.; Sciacca, S.; D’Orazio, N.; Del Rio, D.; Galvano, F. A comprehensive meta-analysis on dietary flavonoid and lignan intake and cancer risk: Level of evidence and limitations. Mol. Nutr. Food Res. 2017, 61, 1600930. [CrossRef] [PubMed]
43. Grosso, G.; Micek, A.; Godos, J.; Pajak, A.; Sciacca, S.; Galvano, F.; Giovannucci, E.L. Dietary flavonoid and lignan intake and mortality in prospective cohort studies: Systematic review and dose-response meta-analysis. Am. J. Epidemiol. 2017, 185, 1304–1316. [CrossRef] [PubMed]
44. Kotsopoulos, J.; Eliassen, A.H.; Missmer, S.A.; Hankinson, S.E.; Tworoger, S.S. Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer 2009, 115, 2765–2774. [CrossRef] [PubMed]
45. Ferrini, R.L.; Barrett-Connor, E. Caffeine intake and endogenous sex steroid levels in postmenopausal women. The rancho bernardo study. Am. J. Epidemiol. 1996, 144, 642–644. [CrossRef] [PubMed]
46. Nagata, C.; Kabuto, M.; Shimizu, H. Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. Nutr. Cancer 1998, 30, 21. [CrossRef] [PubMed]
47. Fung, T.T.; Schulze, M.B.; Hu, F.B.; Hankinson, S.E.; Holmes, M.D. A dietary pattern derived to correlate with estrogens and risk of postmenopausal breast cancer. Breast Cancer Res. Treat. 2012, 132, 1157. [CrossRef] [PubMed]
48. Sisti, J.S.; Hankinson, S.E.; Caporaso, N.E.; Gu, F.; Tamimi, R.M.; Rosner, B.; Xu, X.; Ziegler, R.; Eliassen, A.H. Caffeine, coffee, and tea intake and urinary estrogens and estrogen metabolites in premenopausal women. Cancer Epidemiol. Biomark. Prev. 2015, 24, 1174. [CrossRef] [PubMed]
49. Akash, M.S.; Rehman, K.; Chen, S. Effects of coffee on type 2 diabetes mellitus. Nutrition 2014, 30, 755. [CrossRef] [PubMed]
50. Ortega, Á.; Berná, G.; Rojas, A.; Martín, F.; Soria, B. Gene-diet interactions in type 2 diabetes: The chicken and egg debate. Int. J. Mol. Sci. 2017, 18, 1188. [CrossRef] [PubMed]
51. Lees, B.; Leath, C.A. The impact of diabetes on gynecologic cancer: Current status and future directions. Curr. Obstet. Gynecol. Rep. 2015, 4, 234–239. [CrossRef] [PubMed]
52. Alicandro, G.; Tavani, A.; La Vecchia, C. Coffee and cancer risk: A summary overview. Eur. J. Cancer Prev. 2017, 26, 424–432. [CrossRef] [PubMed]
53. Stocks, T.; Bjorge, T.; Ulmer, H.; Manjer, J.; Haggstrom, C.; Nagel, G.; Engeland, A.; Johansen, D.; Hallmans, G.; Selmer, R.; et al. Metabolic risk score and cancer risk: Pooled analysis of seven cohorts. Int. J. Epidemiol. 2015, 44, 1353–1363. [CrossRef] [PubMed]
54. Renehan, A.G.; Tyson, M.; Egger, M.; Heller, R.F.; Zwahlen, M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371, 569–578. [CrossRef]
55. De Pergola, G.; Silvestris, F. Obesity as a major risk factor for cancer. J. Obes. 2013, 2013, 291546. [CrossRef] [PubMed]
56. Dos Santos, P.R.; Ferrari, G.S.; Ferrari, C.K. Diet, sleep and metabolic syndrome among a legal amazon population, Brazil. Clin. Nutr. Res. 2015, 4, 41–45. [CrossRef] [PubMed]
57. Driessen, M.T.; Koppes, L.L.; Veldhuis, L.; Samoocha, D.; Twisk, J.W. Coffee consumption is not related to the metabolic syndrome at the age of 36 years: The amsterdam growth and health longitudinal study. Eur. J. Clin. Nutr. 2009, 63, 536–542. [CrossRef] [PubMed]
58. Chang, C.S.; Chang, Y.F.; Liu, P.Y.; Chen, C.Y.; Tsai, Y.S.; Wu, C.H. Smoking, habitual tea drinking and metabolic syndrome in elderly men living in rural community: The tianliao old people (TOP) study 02. PLoS ONE 2012, 7, e38874. [CrossRef] [PubMed]
59. Grosso, G.; Marventano, S.; Galvano, F.; Pajak, A.; Mistretta, A. Factors associated with metabolic syndrome in a mediterranean population: Role of caffeinated beverages. J. Epidemiol. 2014, 24, 327–333. [CrossRef] [PubMed]
60. Grosso, G.; Stepaniak, U.; Micek, A.; Topor-Madry, R.; Pikhart, H.; Szafraniec, K.; Pajak, A. Association of daily coffee and tea consumption and metabolic syndrome: Results from the polish arm of the hapiee study. Eur. J. Nutr. 2015, 54, 1129–1137. [CrossRef] [PubMed]
61. Lutsey, P.L.; Steffen, L.M.; Stevens, J. Dietary intake and the development of the metabolic syndrome: The atherosclerosis risk in communities studies. Circulation 2008, 117, 754–761. [CrossRef] [PubMed]
62. Matsuura, H.; Mure, K.; Nishio, N.; Kitano, N.; Nagai, N.; Takeshita, T. Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. J. Epidemiol. 2012, 22, 160–166. [CrossRef] [PubMed]
63. Nordestgaard, A.T.; Thomsen, M.; Nordestgaard, B.G. Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: A Mendelian randomization study. Int. J. Epidemiol. 2015, 44, 551–565. [CrossRef] [PubMed]
64. Takami, H.; Nakamoto, M.; Uemura, H.; Katsuura, S.; Yamaguchi, M.; Hiyoshi, M.; Sawachika, F.; Juta, T.; Arisawa, K. Inverse correlation between coffee consumption and prevalence of metabolic syndrome: Baseline survey of the japan multi-institutional collaborative cohort (J-micc) study in Tokushima, Japan. J. Epidemiol. 2013, 23, 12–20. [CrossRef] [PubMed]
65. Suliga, E.; Koziel, D.; Ciesla, E.; Rebak, D.; Gluszek, S. Coffee consumption and the occurrence and intensity of metabolic syndrome: A cross-sectional study. Int. J. Sci. Nutr. 2016, 68, 507–513. [CrossRef] [PubMed]
66. Micek, A.; Grosso, G.; Polak, M.; Kozakiewicz, K.; Tykarski, A.; Puch Walczak, A.; Drygas, W.; Kwasniewska, M.; Pajak, A. Association between tea and coffee consumption and prevalence of metabolic syndrome in Poland—Results from the WOBASZ II study (2013–2014). Int. J. Food Sci. Nutr. 2017, 1–11. [CrossRef] [PubMed]
67. Aoyagi, R.; Funakoshi-Tago, M.; Fujiwara, Y.; Tamura, H. Coffee inhibits adipocyte differentiation via inactivation of pparγ. Biol. Pharm. Bull. 2014, 37, 1820–1825. [CrossRef] [PubMed]
68. Kearney, J.M.; Kearney, M.J.; McElhone, S.; Gibney, M.J. Methods used to conduct the pan-European Union survey on consumer attitudes to physical activity, body weight and health. Public Health Nutr. 1999, 2, 79–86. [CrossRef] [PubMed]